Skip to main content

Cardiol Therapeutics Inc.

CRDL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001702123

No open-market purchases or sales by Cardiol Therapeutics Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $31.3M in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in Cardiol Therapeutics Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
20
+19 vs. Q2 2021
Shares held
2.64M
+1.51M (+133.2%) vs. Q2 2021
Total value
$12.0M
+$8.63M (+256.3%) vs. Q2 2021
New holders
19
0 more added
Sold out
0
1 more reduced

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CRDL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 20 institutions
Q1 2021: 1 institutionQ2 2021: 1 institutionQ3 2021: 20 institutionsQ4 2021: 34 institutionsQ1 2022: 29 institutionsQ2 2022: 28 institutionsQ3 2022: 27 institutionsQ4 2022: 32 institutionsQ1 2023: 35 institutionsQ2 2023: 33 institutionsQ3 2023: 35 institutionsQ4 2023: 32 institutionsQ1 2024: 35 institutionsQ2 2024: 41 institutionsQ3 2024: 41 institutionsQ4 2024: 43 institutionsQ1 2025: 38 institutionsQ2 2025: 38 institutionsQ3 2025: 48 institutionsQ4 2025: 41 institutionsQ1 2026: 47 institutionsQ2 2026: 52 institutions
Value heldQ3 2021: $12.0M
Q1 2021: $5.09MQ2 2021: $3.37MQ3 2021: $12.0MQ4 2021: $13.1MQ1 2022: $10.1MQ2 2022: $8.58MQ3 2022: $6.25MQ4 2022: $3.64MQ1 2023: $3.54MQ2 2023: $5.97MQ3 2023: $5.78MQ4 2023: $6.02MQ1 2024: $11.7MQ2 2024: $10.8MQ3 2024: $9.85MQ4 2024: $9.60MQ1 2025: $7.44MQ2 2025: $8.80MQ3 2025: $7.80MQ4 2025: $8.69MQ1 2026: $37.6MQ2 2026: $31.3M
Institutions holding CRDL and their total value by quarter
QuarterHoldersValue
Q2 202652$31.3M
Q1 202647$37.6M
Q4 202541$8.69M
Q3 202548$7.80M
Q2 202538$8.80M
Q1 202538$7.44M
Q4 202443$9.60M
Q3 202441$9.85M
Q2 202441$10.8M
Q1 202435$11.7M
Q4 202332$6.02M
Q3 202335$5.78M
Q2 202333$5.97M
Q1 202335$3.54M
Q4 202232$3.64M
Q3 202227$6.25M
Q2 202228$8.58M
Q1 202229$10.1M
Q4 202134$13.1M
Q3 202120$12.0M
Q2 20211$3.37M
Q1 20211$5.09M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Cardiol Therapeutics Inc.; share changes are against Q2 2021.

Institutions holding CRDL in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
AdvisorShares Investments LLC1,029,930$5.38M0.85%−100,365−8.9%Reduced
Mirae Asset Global Investments Co., Ltd.1,043,704$4.30M0.01%+1,043,704New
Renaissance Technologies LLC144,900$598.0K0.00%+144,900New
Jane Street Group, LLC79,431$327.0K0.00%+79,431New
Virtu Financial LLC75,819$315.0K0.03%+75,819New
Geode Capital Management, LLC52,435$217.0K0.00%+52,435New
Vident Investment Advisory, LLC50,566$208.0K0.01%+50,566New
Two Sigma Advisers, LP31,100$129.0K0.00%+31,100New
Morgan Stanley27,090$112.0K0.00%+27,090New
Marble Harbor Investment Counsel, LLC22,000$91.0K0.01%+22,000New
Goldman Sachs Group Inc19,100$79.0K0.00%+19,100New
Advisor Group Holdings, Inc.15,800$65.0K0.00%+15,800New
Royal Bank of Canada14,195$59.0K0.00%+14,195New
Bank of America Corp13,808$57.0K0.00%+13,808New
Federation des caisses Desjardins du Quebec6,000$24.5K0.00%+6,000New
Private Ocean, LLC5,500$23.0K0.00%+5,500New
Tower Research Capital LLC (TRC)2,161$9.00K0.00%+2,161New
Toronto Dominion Bank882$4.00K0.00%+882New
Piscataqua Savings Bank1,000$4.00K0.00%+1,000New
Tradewinds Capital Management, LLC500$2.00K0.00%+500New